Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Anavex Life Sciences Corp. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 181 | 2 | 178 | −1 |
| Shares | 31.4M | 13.2K | 32.5M | +1.14M (+3.6%) |
| Value | $269.2M | $112.9K | $301.9M | +$32.8M (+12.2%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Anavex Life Sciences Corp. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Summit Financial, LLC | 222,978 | $2.06M | 0.05% |
| Sculptor Capital LP | 155,900 | $1.44M | 0.02% |
| October Effect Ltd | 116,546 | $1.07M | 1.30% |
| Stratos Wealth Partners, LTD. | 26,600 | $245.3K | 0.00% |
| Corton Capital Inc. | 24,517 | $226.0K | 0.26% |
| Jane Street Group, LLC | 17,681 | $163.0K | 0.00% |
| American Century Companies Inc | 14,667 | $135.2K | 0.00% |
| Squarepoint Ops LLC | 10,744 | $99.1K | 0.00% |
| Prudential Financial Inc | 10,345 | $95.4K | 0.00% |
| Weaver Consulting Group | 10,166 | $93.7K | 0.03% |
| Kovack Advisors, Inc. | 10,100 | $93.1K | 0.01% |
| STRS Ohio | 7,700 | $71.0K | 0.00% |
| Millstone Evans Group, LLC | 3,000 | $27.7K | 0.02% |
| State of Wyoming | 2,849 | $26.3K | 0.00% |
| GWM Advisors LLC | 1,626 | $15.0K | 0.00% |
| Kilter Group LLC | 1,597 | $14.7K | 0.01% |
| Graney & King, LLC | 1,000 | $9.22K | 0.01% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 909 | $8.00K | 0.00% |
| MAI Capital Management | 310 | $2.86K | 0.00% |
| Glenmede Investment Management, LP | 288 | $2.65K | 0.00% |
| Federated Hermes, Inc. | 130 | $1.20K | 0.00% |
| Skopos Labs, Inc. | 78 | $720 | 0.00% |
| Assetmark, Inc | 76 | $701 | 0.00% |
| Twin Peaks Wealth Advisors, LLC | 1 | $11 | 0.00% |
Sold out (25)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Millennium Management LLC | 340,019 | $2.92M |
| Trexquant Investment LP | 71,107 | $610.1K |
| MetLife Investment Management | 45,343 | $389.0K |
| Corebridge Financial, Inc. | 36,760 | $315.4K |
| DnB Asset Management AS | 33,261 | $285.4K |
| Gsa Capital Partners LLP | 27,684 | $238.0K |
| Virtu Financial LLC | 25,895 | $222.0K |
| SG Americas Securities, LLC | 25,242 | $217.0K |
| ExodusPoint Capital Management, LP | 20,000 | $172.0K |
| Axq Capital, LP | 17,888 | $153.5K |
| Renaissance Technologies LLC | 14,000 | $120.1K |
| Brevan Howard Capital Management LP | 10,932 | $93.8K |
| Simplex Trading, LLC | 10,427 | $89.0K |
| D.A. Davidson & Co. | 10,335 | $88.7K |
| Engineers Gate Manager LP | 10,283 | $88.2K |
| Quest Partners LLC | 7,741 | $66.4K |
| Quadrant Capital Group LLC | 2,611 | $22.4K |
| CoreCap Advisors, LLC | 660 | $5.66K |
| Roxbury Financial LLC | 580 | $4.59K |
| Boston Private Wealth LLC | 382 | $3.28K |
| Caitong International Asset Management Co., Ltd | 297 | $2.55K |
| Smartleaf Asset Management LLC | 184 | $1.60K |
| Rise Advisors, LLC | 125 | $1.07K |
| SRS Capital Advisors, Inc. | 87 | $747 |
| Stephens Consulting, LLC | 40 | $344 |
Not filed for Q2 2025 yet (2)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sheaff Brock Investment Advisors, LLC | 11,250 | $96.5K |
| Lindbrook Capital, LLC | 1,914 | $16.4K |